NGFR and Alzheimer disease: When crossed with transgenic mice with APP mutations (models of Alzheimer’s disease with amyloid plaque formation and memory deficits), p75NTR knockout mice showed a reduced degeneration in cholinergic neurites despite no reduction in Aβ levels.